Pharmacology Flashcards

1
Q

What is the mechanism of action of the sulfonylureas?

A

Act by displacing the binding of ADP-Mg2+ from the SUR1 subunit (thus closing the KATP channel and stimulating insulin release)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Why would sulfonylureas not work in type 1 diabetes?

A

They increase insulin release from beta cells, in type 1 diabetes there are no functioning beta cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Examples of sulfonylureas?

A

tolbutamide, gliclazide, glibenclamide, glipizide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Tolbutamide, gliclazide, glibenclamide, glipizide are all examples of…

A

Sulfonylureas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What drugs for T2DM can cause hypos?

A

Sulfonylureas, Glinides (less likely than SUs),

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Hypoglycaemia by excessive insulin secretion is a side effect of the sulfonylureas, who is more at risk of this side effect?

A

long acting agents (e.g. glibenclamide)
the elderly
patients with reduced hepatic/renal function, particularly chronic kidney disease (CKD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Explain how the sulfonyureas can cause weight gain?

A

anabolic effect of insulin increased
appetite increased
urinary loss of glucose decreased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

When are the sulfonyureas used?

A

first-line in patients intolerant of metformin, or with weight loss
second-line in conjunction with metformin
third line in conjunction with metformin and thiazolidinediones, or other drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Mechanism of action of the glinides?

A

Almost the same as sulfonylureas but binding is slightly different

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Examples of the glinides?

A

Repaglinide and nateglinide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Repaglinide is subject to mainly hepatic metabolism – thus safer than SUs in ______

A

chronic kidney disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the incretin response, what two drugs for type 2 diabetes target this?

A

• Ingestion of food stimulates release of GLP-1 and IP from enteroendocrine cells in the small intestine (L cells in the ileum and K cells in the duodenum, respectively
• These enter the portal blood enhancing insulin release
• GLP-1 also decrease glucagon release
Hence blood glucose is decreased

The DPP-4 inhibitors and the incretin analogues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the mechanism of action of the DPP-4 inhibitors

A

• The incretin response is reduced in type 2 so this drug tries to restore it pharmacology
• Action of GLP 1 and GIP are very rapidly terminated by the enzyme DPP 4
The Gliptins competitively inhibit DPP-4 prolonging the actions of endogenous GLP-1 and GIP and increasing plasma insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Repaglinide and nateglinide and examples of?

A

Glinides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why are drugs that target the incretin response only helpful in type 2 diabetes?

A

They target a response which helps with insulin secretion, if no insulin secretion in the first place this is not helpful.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Examples of Gliptins/ DPP-4 inhibitors?

A

sitagliptin, saxagliptin, vildagliptin, linagliptin and alogliptin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Sitagliptin, saxagliptin, vildagliptin, linagliptin and alogliptin are all examples of?

A

Gliptins/ DPP-4 inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Main adverse effect of the gliptins?

A

Nausea

No hypos and weight neutral

19
Q

When are the gliptins usually used?

A

In combination with a SU, or metformin, but can be employed as monotherapy

20
Q

Describe the mechanism of action of incretin analogues?

A

peptides that mimic the action of GLP-1 but resist breakdown by DPP-4

21
Q

Do incretin analogues help lose weight? How?

A

Yes
suppress glucagon secretion
slow gastric emptying
decrease appetite (hypothalamic action)

22
Q

When are incretin analogues used?

A

Not first line, usually as an add on therapy particularly those with cardiovascular risk.

23
Q

Adverse effects of the incretin analogues?

A

No hypos
May cause nausea
Very occasionally pancreatitis

24
Q

Mechanism of action of alpha glucosidase inhibitors?

A

Alpha- Glucosidase is a brush border enzyme that breaks down starch and disaccharides to absorbable glucose. Therefore Inhibitors of alpha-glucosidase (e.g. acarbose, miglitol, voglibose) taken with a meal delay absorption of glucose and reduce postprandial increase in blood glucose

25
Q

When are alpha glucosidase inhibitors used?

A

Used in 2TDM patients inadequately controlled by life style measures or other drugs (e.g. SUs)

26
Q

Adverse effects of alpha glucosidase inhibitors?

A

GI upset—> flatulence, loose stools, diarrhoea, abdominal pain, bloating
no hypos

27
Q

Are alpha glucosidase inhibitors used a lot?

A

NO

Although they pose no risk of hypos the glycemic control is modest

28
Q

Examples of alpha glucosidase inhibitors?

A

acarbose, miglitol, voglibose

29
Q

Acarbose, miglitol, voglibose are examples of?

A

alpha glucosidase inhibitors

30
Q

The only therapeutic agent in the biguanides is…

A

metformin

31
Q

What is the first line agent in treatment of type 2 diabetes?

A

Metformin

32
Q

Mechanism of metformin?

A

reduces hepatic gluoconeogenesis [by stimulating AMP-activated protein kinase (AMPK)]
increases glucose uptake and utilization by skeletal muscle (increases insulin signalling)
reduces carbohydrate absorption
increases fatty acid oxidation

33
Q

5 desirable effects of metformin?

A

reduces the microvascular complications
suitable for oral administration
prevents hyperglycaemia but does not cause hypoglycaemia
causes weight loss (unlike insulin and some agents that promote insulin release)
may be combined with other agents (e.g. insulin, thiazolidinediones, sulfonylureas)

34
Q

2 adverse effects of metformin?

A
gastrointestinal upsets (diarrhoea, nausea, anorexia)
rarely lactic acidosis (avoid routine use in patients with significant hepatic, or renal, disease). Excessive alcohol consumption may increase the incidence of lactic acidosis
35
Q

Mechanism of action of Thiazolidinediones?

A

exogenous agonists of the nuclear receptor peroxyisome profilerator-activated receptor- (PPAR) which associates with retinoid receptor X (RXR) - PPAR is largely confined to adipocytes
Activated PPAR-RXR complex acts as a transcription factor that promotes the expression of genes encoding several proteins involved in insulin signalling and lipid metabolism

36
Q

Pioglitazone, ciglitazone, troglitazone are all examples of?

A

Thiazolidinediones

37
Q

Explain if thiazolidinediones cause weight gain?

A

They do as they are promoting storage of fat in the adipocytes

38
Q

When are thiazolidinediones used?

A

in combination with either metformin, or SUs, to achieve adequate control of blood glucose

39
Q

Examples of thiazolidinediones?

A

Pioglitazone, ciglitazone, troglitazone

40
Q

Mechanism of SGLT2 inhibitors?

A

Act to selectively block the reabsorption of glucose by SGLT2 in the proximal tubule of the kidney nephron to deliberately cause glucosuria
Cause a decrease in blood glucose with little risk of hypoglycaemia

41
Q

How do SGLT2 inhibitors cause weight loss?

A

Calorific loss (i.e. glucose voided) and water accompanying glucose (i.e. osmotic diuresis) contributes to weight loss

42
Q

Examples of SGLT2 inhibitors?

A

dapagliflozin, canagliflozin and empagliflozin

43
Q

Dapagliflozin, canagliflozin and empagliflozin are examples of?

A

SGLT2 inhibitors

44
Q

Does metformin help with microvascular complications?

A

YES! it reduces them :)